PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China · Delayed Price · Currency is CNY 34.34
-1.27 (-3.57%)
At close: Jun 2, 2026
SHE:301230 Market Cap
SHE:301230 has a market cap or net worth of 4.72 billion as of June 2, 2026. Its market cap has increased by 15.90% in one year.
Market Cap
4.72B
Enterprise Value
4.59B
Revenue
691.21M
Ranking
n/a
PE Ratio
107.72
Stock Price
34.34
Market Cap Chart
Since November 1, 2022, SHE:301230's market cap has increased from 3.94B to 4.72B, an increase of 19.93%. That is a compound annual growth rate of 5.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 4.90B | 19.22% |
| Dec 31, 2025 | 4.11B | 17.05% |
| Dec 31, 2024 | 3.51B | -8.90% |
| Dec 29, 2023 | 3.85B | -6.18% |
| Dec 30, 2022 | 4.11B | 4.27% |
| Nov 1, 2022 | 3.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hangzhou Biotest Biotech | 5.57B |
| Beijing Konruns Pharmaceutical | 5.39B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.37B |
| R&G PharmaStudies | 4.81B |
| Lifecome Biochemistry | 4.57B |
| Jiangsu Bioperfectus Technologies | 4.47B |
| Assure Tech (Hangzhou) | 4.42B |
| Zhejiang Wecome Pharmaceutical Company | 4.38B |